A randomized, open, parallel-group study to evaluate the efficacy of three different patient management strategies during a 12 weeks maintenance phase following an initial 4-weeks acute treatment phase in subjects with symptoms thought to be GERD [gastroesophageal reflux disease] related

Trial Profile

A randomized, open, parallel-group study to evaluate the efficacy of three different patient management strategies during a 12 weeks maintenance phase following an initial 4-weeks acute treatment phase in subjects with symptoms thought to be GERD [gastroesophageal reflux disease] related

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2012

At a glance

  • Drugs Esomeprazole (Primary) ; Antacids
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Acronyms MAESTRO
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Oct 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 20 Jul 2008 Planned patient number changed from 6000 to 1000 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top